Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what plans he has to reduce diagnosis times for leukaemia in Shropshire, Telford and Wrekin.

Early diagnosis is a key focus of the National Cancer Plan. The Government is committed to supporting the National Health Service to diagnose cancer, including leukaemia, as early and quickly as possible and to improve outcomes for patients.

To support earlier diagnosis of blood cancers, including leukaemia, NHS England has implemented non-specific symptom pathways for patients presenting with symptoms such as unexplained weight loss and fatigue that do not clearly align to a particular tumour type. Blood cancers, including leukaemia, are among the most common cancers diagnosed through these pathways.

Recognising that leukaemia is not captured by the current stage-based measure of early diagnosis, the National Cancer Plan commits to publishing regular data on the number of these cancers diagnosed in emergency settings, as a proxy for late or ineffective diagnosis. Adding this to the basket of early diagnosis metrics will help incentivise systems and providers to focus on earlier diagnosis of blood cancers.

The National Cancer Plan also includes measures to strengthen diagnostic services by investing in diagnostic capacity and expanding access to tests and scans. Community diagnostic centres are playing an important role in supporting earlier diagnosis, with 109 centres now open 12 hours a day, seven days a week, offering at least one diagnostic test during extended hours. The Government also plans to open four additional community diagnostic centres, helping more patients access diagnostic services closer to home and at times that fit around work and family commitments.

The plan will also support earlier diagnosis through the wider use of innovative technologies, including artificial intelligence, where supported by evidence, and by ensuring every patient who would benefit from a genomic test can receive one within a clinically relevant timeframe.

Recognising that blood cancers such as leukaemia do not behave like many other cancers and are not captured by stage-based early diagnosis metrics, the National Cancer Plan also commits to publishing regular data on the number of these cancers diagnosed in emergency settings. This will improve understanding of diagnostic performance, help identify where further intervention is needed, and support earlier diagnosis of leukaemia and other blood cancers.